Property | Value |
?:abstract
|
-
Patients with novel coronavirus disease 2019 (COVID-19) experience various degrees of liver function abnormalities. Liver injury requires extensive work-up and continuous surveillance and can be multifactorial and heterogeneous in nature. In the context of COVID-19, clinicians will have to determine whether liver injury is related to an underlying liver disease, drugs used for the treatment of COVID-19, direct effect of the virus, or a complicated disease course. Recent studies proposed several theories on potential mechanisms of liver injury in these patients. This review summarizes current evidence related to hepatobiliary complications in COVID-19, provides an overview of the available case series and critically elucidates the proposed mechanisms and provides recommendations for clinicians.
|
?:creator
|
|
?:doi
|
|
?:doi
|
|
?:journal
|
-
United_European_Gastroenterol_J
|
?:license
|
|
?:pdf_json_files
|
-
document_parses/pdf_json/ad87636808fcce62fd2fe5f50c968b604dc21197.json
|
?:pmc_json_files
|
-
document_parses/pmc_json/PMC7268949.xml.json
|
?:pmcid
|
|
?:pmid
|
|
?:pmid
|
|
?:publication_isRelatedTo_Disease
|
|
?:sha_id
|
|
?:source
|
|
?:title
|
-
Liver injury in COVID-19: The current evidence
|
?:type
|
|
?:year
|
|